Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0GZ5F
|
||||
| Former ID |
DIB009288
|
||||
| Drug Name |
CX-1001
|
||||
| Synonyms |
SERT ligand (cancer), Celentyx; Reprofiled marketed drug (B-cell cancers), Celentyx
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543976] | ||
| Company |
Celentyx Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent serotonin transporter | Target Info | Binder | [543976] | |
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.